We are live on ! Find out more
GOVX icon

GeoVax Labs

16 hedge funds and large institutions have $3.39M invested in GeoVax Labs in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 2

157% more capital inflows, than outflows

Capital inflows: $3.25M | Capital outflows: $1.26M

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

23% more funds holding

Funds holding: 13 → 16 (+3)

2.73% more ownership

Funds ownership: 9.85% → 12.58% (+2.7%)

Holders
16
Holders Change
+3
Holders Change %
+23.08%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
6
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

GOVX Hedge Fund Activity: Q3 2022 in Review

16 of the 5,834 institutional investors tracked by Wall St. Rank reported a position in GeoVax Labs (GOVX) for Q3 2022, worth a combined $3.39M — up 68% from $2.02M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new GOVX positions and 3 closed out — a net gain of 3 holders — while 6 added to existing stakes and 2 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $982K. The largest seller was Armistice Capital, exiting entirely with an estimated $1.13M sold.

  • 16 institutional investors held GeoVax Labs (GOVX) as of Q3 2022, up from 13 in Q2 2022.
  • Funds reported $3.39M of GeoVax Labs stock for Q3 2022, up 68% quarter-over-quarter.
  • 6 funds opened new GeoVax Labs positions in Q3 2022 and 3 closed out, a net change of +3 holders.
  • The largest GeoVax Labs buyer in Q3 2022 was Renaissance Technologies, an estimated $982K added.
  • The largest GeoVax Labs seller in Q3 2022 was Armistice Capital, an estimated $1.13M sold.

Based on aggregated 13F filings for Q3 2022.